approval · primary record
PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF
FDA · BLA · 2026-05-18
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2026-05-18 |
| Brand | PHESGO |
| Sponsor | GENENTECH INC |
| Route | SUBCUTANEOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T03:31:17.881Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF:2026-05-18
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.